Sarepta Therapeutics, Inc.
Price Action
Technical Summary
WEAKENINGSarepta Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 36), showing significant lag compared to the market leaders. Earnings growth of 163% provides fundamental context to the price action. Investors should exercise caution due to high volatility (94% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $16.94 | +16.82% | ABOVE |
| 50 SMA | $18.02 | +9.83% | ABOVE |
| 100 SMA | $18.61 | +6.37% | ABOVE |
| 150 SMA | $19.51 | +1.44% | ABOVE |
| 200 SMA | $19.72 | +0.37% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SRPT in an uptrend right now?
SRPT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SRPT overbought or oversold?
SRPT's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is SRPT outperforming the market?
SRPT has a Relative Strength (RS) Rating of 36 out of 99. SRPT is currently lagging the broader market.
Where is SRPT in its 52-week range?
SRPT is trading at $19.79, which is 78% of its 52-week high ($25.32) and 63% above its 52-week low ($10.42).
How volatile is SRPT?
SRPT has a Beta of 2.28 and 52-week volatility of 94%. It's more volatile than the S&P 500 - expect bigger swings.